BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15988011)

  • 1. Mip1, an MEKK2-interacting protein, controls MEKK2 dimerization and activation.
    Cheng J; Zhang D; Kim K; Zhao Y; Zhao Y; Su B
    Mol Cell Biol; 2005 Jul; 25(14):5955-64. PubMed ID: 15988011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimerization through the catalytic domain is essential for MEKK2 activation.
    Cheng J; Yu L; Zhang D; Huang Q; Spencer D; Su B
    J Biol Chem; 2005 Apr; 280(14):13477-82. PubMed ID: 15695508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in fibroblasts.
    Kesavan K; Lobel-Rice K; Sun W; Lapadat R; Webb S; Johnson GL; Garrington TP
    J Cell Physiol; 2004 Apr; 199(1):140-8. PubMed ID: 14978743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic interaction of MEK kinase 2, c-Jun N-terminal kinase (JNK) kinase 2, and JNK1 results in efficient and specific JNK1 activation.
    Cheng J; Yang J; Xia Y; Karin M; Su B
    Mol Cell Biol; 2000 Apr; 20(7):2334-42. PubMed ID: 10713157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src.
    Sun W; Wei X; Kesavan K; Garrington TP; Fan R; Mei J; Anderson SM; Gelfand EW; Johnson GL
    Mol Cell Biol; 2003 Apr; 23(7):2298-308. PubMed ID: 12640115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis.
    Hammaker DR; Boyle DL; Chabaud-Riou M; Firestein GS
    J Immunol; 2004 Feb; 172(3):1612-8. PubMed ID: 14734742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway.
    Sun W; Kesavan K; Schaefer BC; Garrington TP; Ware M; Johnson NL; Gelfand EW; Johnson GL
    J Biol Chem; 2001 Feb; 276(7):5093-100. PubMed ID: 11073940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEKK2 is required for T-cell receptor signals in JNK activation and interleukin-2 gene expression.
    Su B; Cheng J; Yang J; Guo Z
    J Biol Chem; 2001 May; 276(18):14784-90. PubMed ID: 11278622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in protein kinase subdomain X differentially affect MEKK2 and MEKK1 activity.
    Huang J; Tu Z; Lee FS
    Biochem Biophys Res Commun; 2003 Apr; 303(2):532-40. PubMed ID: 12659851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEF2C regulates c-Jun but not TNF-alpha gene expression in stimulated mast cells.
    Wei X; Sun W; Fan R; Hahn J; Joetham A; Li G; Webb S; Garrington T; Dakhama A; Lucas J; Johnson GL; Gelfand EW
    Eur J Immunol; 2003 Oct; 33(10):2903-9. PubMed ID: 14515274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of MEKK2-MEK5 in the regulation of TNF-alpha gene expression and MEKK2-MKK7 in the activation of c-Jun N-terminal kinase in mast cells.
    Chayama K; Papst PJ; Garrington TP; Pratt JC; Ishizuka T; Webb S; Ganiatsas S; Zon LI; Sun W; Johnson GL; Gelfand EW
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4599-604. PubMed ID: 11274363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative regulation of MEKK1/2 signaling by serine-threonine kinase 38 (STK38).
    Enomoto A; Kido N; Ito M; Morita A; Matsumoto Y; Takamatsu N; Hosoi Y; Miyagawa K
    Oncogene; 2008 Mar; 27(13):1930-8. PubMed ID: 17906693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEKK2 gene disruption causes loss of cytokine production in response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells.
    Garrington TP; Ishizuka T; Papst PJ; Chayama K; Webb S; Yujiri T; Sun W; Sather S; Russell DM; Gibson SB; Keller G; Gelfand EW; Johnson GL
    EMBO J; 2000 Oct; 19(20):5387-95. PubMed ID: 11032806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEKK2 kinase association with 14-3-3 protein regulates activation of c-Jun N-terminal kinase.
    Matitau AE; Gabor TV; Gill RM; Scheid MP
    J Biol Chem; 2013 Sep; 288(39):28293-302. PubMed ID: 23963453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors.
    Lee CM; Onésime D; Reddy CD; Dhanasekaran N; Reddy EP
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14189-94. PubMed ID: 12391307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of phosphatidylinositol 3-kinase and c-Jun-N-terminal kinase cascades enhances NF-kappaB-dependent gene transcription in BCG-stimulated macrophages through promotion of p65/p300 binding.
    Darieva Z; Lasunskaia EB; Campos MN; Kipnis TL; Da Silva WD
    J Leukoc Biol; 2004 Apr; 75(4):689-97. PubMed ID: 14742634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42.
    Fanger GR; Johnson NL; Johnson GL
    EMBO J; 1997 Aug; 16(16):4961-72. PubMed ID: 9305638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells.
    Saatian B; Zhao Y; He D; Georas SN; Watkins T; Spannhake EW; Natarajan V
    Biochem J; 2006 Feb; 393(Pt 3):657-68. PubMed ID: 16197369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes.
    Wu CJ; Qian X; O'Rourke DM
    DNA Cell Biol; 1999 Oct; 18(10):731-41. PubMed ID: 10541432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of MEKK2/3 serine phosphorylation site targeted by the Toll-like receptor and stress pathways.
    Zhang D; Facchinetti V; Wang X; Huang Q; Qin J; Su B
    EMBO J; 2006 Jan; 25(1):97-107. PubMed ID: 16362041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.